Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOLAN: Inhaled Epoprostenol and Phenylephrine in One Lung Ventilation
NCT02748265Phase 4Completed
- Sponsor
- University Health Network
- Start
- Mar 2016
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of epoprostenol in hypoxemia, sponsored by University Health Network. Started Mar 2016; status: completed.
02
Drugs
epoprostenol
03
Conditions
hypoxemia
Beyond the preview
Go deeper on NCT02748265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748265.